share_log

While Individual Investors Own 23% of Cofoe Medical Technology Co.,Ltd. (SZSE:301087), Private Companies Are Its Largest Shareholders With 47% Ownership

While Individual Investors Own 23% of Cofoe Medical Technology Co.,Ltd. (SZSE:301087), Private Companies Are Its Largest Shareholders With 47% Ownership

虽然个人投资者拥有科富医疗科技股份有限公司(SZSE:301087)的23%股权,但私营公司是其最大股东,拥有47%的股份。
Simply Wall St ·  11/04 20:57

Key Insights

  • The considerable ownership by private companies in Cofoe Medical TechnologyLtd indicates that they collectively have a greater say in management and business strategy
  • A total of 3 investors have a majority stake in the company with 53% ownership
  • 11% of Cofoe Medical TechnologyLtd is held by insiders

To get a sense of who is truly in control of Cofoe Medical Technology Co.,Ltd. (SZSE:301087), it is important to understand the ownership structure of the business. We can see that private companies own the lion's share in the company with 47% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

And individual investors on the other hand have a 23% ownership in the company.

Let's delve deeper into each type of owner of Cofoe Medical TechnologyLtd, beginning with the chart below.

big
SZSE:301087 Ownership Breakdown November 5th 2024

What Does The Institutional Ownership Tell Us About Cofoe Medical TechnologyLtd?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Cofoe Medical TechnologyLtd already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Cofoe Medical TechnologyLtd's earnings history below. Of course, the future is what really matters.

big
SZSE:301087 Earnings and Revenue Growth November 5th 2024

Cofoe Medical TechnologyLtd is not owned by hedge funds. Changsha Xiezihao Medical Investment Co., Ltd. is currently the largest shareholder, with 41% of shares outstanding. The second and third largest shareholders are Min Zhang and Changsha Keyuan Tongchuang Enterprise Management Center (Limited Partnership), with an equal amount of shares to their name at 5.8%. Min Zhang, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 53% stake.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

Insider Ownership Of Cofoe Medical TechnologyLtd

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

It seems insiders own a significant proportion of Cofoe Medical Technology Co.,Ltd.. It is very interesting to see that insiders have a meaningful CN¥878m stake in this CN¥7.8b business. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 23% stake in Cofoe Medical TechnologyLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Company Ownership

It seems that Private Companies own 47%, of the Cofoe Medical TechnologyLtd stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Cofoe Medical TechnologyLtd you should know about.

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发